Pharmaceuticals and pharmaceutical products for treating friedreich's ataxia, huntington's disease, myotonic dystrophy, spinocerebellal ataxia, fragile-x syndrome and other neuromuscular, metabolic, autoimmune, cardiovascular, hyperplastic diseases that respond to ribonucleic acid (RNA)-based therapies; pharmaceuticals comprising drugs based on oligonucleotides and drugs that modulate RNA expression

'acid':33 'ataxia':9,16 'autoimmun':25 'base':35,40 'cardiovascular':26 'compris':38 'diseas':12,28 'drug':39,44 'dystrophi':14 'express':48 'fragil':18 'fragile-x':17 'friedreich':7 'huntington':10 'hyperplast':27 'metabol':24 'modul':46 'myoton':13 'neuromuscular':23 'oligonucleotid':42 'pharmaceut':1,3,37 'product':4 'respond':30 'ribonucl':32 'rna':34,47 'spinocerebel':15 'syndrom':20 'therapi':36 'treat':6 'x':19

ITTERO THERAPEUTICS

Owner

Goods & Services